PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

Eli Lilly &

Organization identified through public comments on regulations.gov

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$50,000

Connections

11

Coalition view

Eli Lilly & operates as part of a multi-committee coalition with ELI LILLY AND COMPANY POLITICAL ACTION COMMITTEE. Combined tracked totals across all coalition members below give the figure most public sources quote (Sludge, JNS, OpenSecrets).

Combined tracked giving

$307,000

Combined tracked receipts

$387,848

Combined lobbying spend

$50,000

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

DEFDefense
$50K
PHAPharmacy
$50K
MMMMedicare/Medicaid
$50K
BUDBudget/Appropriations
$50K
TRDTrade
$50K
TAXTaxation/Internal Revenue Code
$50K
HCRHealth Issues
$50K

Lobbying Firms Retained

WILLIAMS AND JENSEN, PLLC$50K

Bills Referenced in Lobbying Filings

march-in

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byWILLIAMS AND JENSEN, PLLCHired WILLIAMS AND JENSEN, PLLC to lobby on NIH March-In RightsSource
Advocated forInsulin Price Caps - State-Level LegislationEli Lilly was the first major manufacturer to voluntarily cap insulin prices at $35Source
Coalition withPharmaceutical industryEli Lilly is the most valuable pharmaceutical company by market capEditorial
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2023-0127: Request for Information: Episode-based Payment ModelSource
Employed byTIBER CREEK HEALTH STRATEGIES, INC.Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PharmaceuticalsSource
Employed byTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby on PharmaceuticalsSource
Employed byTHE SIMMONS & RUSSELL GROUP, LLCHired THE SIMMONS & RUSSELL GROUP, LLC to lobby on Insulin Price CapsSource
Funded research atThe Heritage FoundationEli Lilly donor to Heritage FoundationEditorial
EmployedDavid RicksChairman and CEO of Eli Lilly since 2017Editorial
Has as instrumentELI LILLY AND COMPANY POLITICAL ACTION COMMITTEEEli Lilly PAC is the political arm of Eli Lilly and CompanyEditorial